Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Freedom Bunker
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Airbus Shares Hit Turbulence After Dismal Delivery Outlook

% of readers think this story is Fact. Add your two cents.


Airbus Shares Hit Turbulence After Dismal Delivery Outlook

Shares of Airbus SE plunged as much as 8% in Paris trading after the aerospace and defense group guided to 870 commercial aircraft deliveries for 2026, well below the Bloomberg Consensus estimate of 896. Airbus blamed the softer outlook on the lack of reliable engine supplies for its A320 family of jets.

UBS analyst Tricia Wright said fourth-quarter results were in line, but the 2026 guidance was at the low end of expectations, and long-term production targets were downgraded.

“While the possibility of a long-term production rate target downgrade had been discussed by investors, 2026 guidance is also below the expectations of most investors we spoke to—880 deliveries, €7.5–8 billion EBIT, and €5–5.5 billion FCF,” said UBS analyst Ian Douglas-Pennant. The analyst reiterated his “buy” rating on Airbus.

The lower guidance was largely due to what CEO Guillaume Faury called a “significant” shortage of engines from Pratt & Whitney. He said this forced the planemaker into a mad dash to meet last year’s delivery target, which was ultimately lowered in the final weeks of the year.

Pratt & Whitney’s failure to commit to the number of engines ordered by Airbus is negatively impacting this year’s guidance and the ramp-up trajectory,” Airbus wrote in a statement.

Here’s a snapshot of the 2026 full-year forecast (courtesy of Bloomberg):

  • Sees commercial aircraft deliveries of about 870 planes; estimate 895.74 (Bloomberg Consensus)

  • Sees adjusted EBIT of about €7.5 billion; estimate €8.19 billion

  • Sees adjusted free cash flow of about €4.5 billion; estimate €5.68 billion

Goldman analyst Jeremy Elster commented on bearish technicals developing for the planemaker:

AIRBUS trading down -8%, breaking 200dma and breaching lows of recent range –

Feedback: guide came in at lower end – per comment yesterday; at €200 I would argue the shares are pricing in an €~8bn ebit guide. At closer to €190 we had more fully priced >€7.5bn. Feedback is mostly arguing to defend this as yet another Airbus “clearing event”, but it is clear that conviction is fragile in the currently rather volatile tape.

In the numbers: headline item is ’26 guide at 870 aircraft, ebit “around 7.5bn”, and cash flow “around 4.5bn”. Implied consensus downgrade is m to hsd. The company cite continued “failure to commit” from Pratt as holding up engine deliveries. The ramp-up guide is tweaked to now assume rate 70-75 by the end of 2027 (previously 75) and to stabilise at rate 75 “thereafter” (consensus has rates reaching this cadence only in ’29/30).

After the call – a few more reasons for optimism than is typical from Airbus. Key soundbites:

  • “guidance does not reflect any concern on a per aircraft basis. the margins are healthy”.

  • “FCF main impact is Spirit now being worse because of late deal close leading to spill over into ’26″

  • Engines (the key topic) – “Pratt issues will mainly impact ’26 and to some extent ’27″. “we continue to pursue reaching rate 75 by end of next year, but due to uncertainty on engine volumes we changed the guide to 70-75″… “as we navigate the relationship with Pratt we want to preserve the possibility to have better news at a later stage”. 

Shares of Airbus in Paris tumbled as much as 8.1% following the downgraded full-year update on aircraft deliveries.

Elster noted, “Airbus looking technically fragile, despite an update that could / should have reassured…” 

Airbus deliveries in January fell to their lowest level since 2020, marking the weakest start to a year in at least a decade. By contrast, rival Boeing has continued to recover from yearslong 737 MAX crisis and recently posted its highest commercial aircraft deliveries since 2018.

Tyler Durden Thu, 02/19/2026 – 07:45


Source: https://freedombunker.com/2026/02/19/airbus-shares-hit-turbulence-after-dismal-delivery-outlook/


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login